2010
DOI: 10.1136/tc.2009.031567
|View full text |Cite
|
Sign up to set email alerts
|

Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial

Abstract: The 16 mg Ruyan V8 ENDD alleviated desire to smoke after overnight abstinence, was well tolerated and had a pharmacokinetic profile more like the Nicorette inhalator than a tobacco cigarette. Evaluation of the ENDD for longer-term safety, potential for long-term use and efficacy as a cessation aid is needed. Trial registration No.12607000587404, Australia and New Zealand Clinical Trials Register.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

13
418
3
14

Year Published

2012
2012
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 453 publications
(448 citation statements)
references
References 15 publications
13
418
3
14
Order By: Relevance
“…The highly significant reduction in desire to smoke, despite the fact that participants were unable to accurately detect on which occasion they had received nicotine, is consistent with previous studies that the nicotine e-cigarette is capable of reducing tobacco craving in abstinent smokers (Bullen et al 2010;Dawkins et al 2012;Vansickel et al 2010). Total MPSS scores were also significantly lower in the nicotine versus the placebo condition consistent with an attenuating effect of the nicotine e-cigarette on tobacco-related withdrawal symptoms.…”
supporting
confidence: 86%
See 3 more Smart Citations
“…The highly significant reduction in desire to smoke, despite the fact that participants were unable to accurately detect on which occasion they had received nicotine, is consistent with previous studies that the nicotine e-cigarette is capable of reducing tobacco craving in abstinent smokers (Bullen et al 2010;Dawkins et al 2012;Vansickel et al 2010). Total MPSS scores were also significantly lower in the nicotine versus the placebo condition consistent with an attenuating effect of the nicotine e-cigarette on tobacco-related withdrawal symptoms.…”
supporting
confidence: 86%
“…The experimenter then introduced the participant to the e-cigarette explaining and demonstrating how to use it before allowing the participant to use it ad libitum for ten minutes. Participants were then asked to wait for 15 minutes (to allow time for the nicotine to reach maximum plasma concentration; Bullen et al 2010;Vansickle and Eissenberg 2012) during which time they completed basic demographic information and the FTND (time 1 only). After 15 minutes, participants then completed the MPSS and desire to smoke scales followed by the CAMPROMPT.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Few studies have explored blood nicotine delivery via the e-cigarette although two early studies reported ineffective nicotine delivery with naïve users using first generation e-cigarettes. Bullen et al (2010) observed a peak serum nicotine level of only 1.3 ng/ml in 19.6 min and Vansickel et al (2010) reported that two different brands of e-cigarettes failed to raise blood nicotine levels significantly over a 45 min period.…”
Section: Introductionmentioning
confidence: 99%